General Information of Drug (ID: DMUAOFM)

Drug Name
PF-06290510 Drug Info
Indication
Disease Entry ICD 11 Status REF
Major depressive disorder 6A70.3 Phase 2 [1]
Staphylococcus infection 1B5Y Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMUAOFM

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Staphylococcus Capsular polysaccharide CP5 (Stap-coc CP5) TTE6QWF NOUNIPROTAC Not Available [2]
Staphylococcus Capsular polysaccharide CP8 (Stap-coc CP8) TT4SVB7 NOUNIPROTAC Not Available [2]
Staphylococcus Clumping factor A (Stap-coc ClfA) TTWGZ64 CLFA_STAA8 Not Available [2]
Staphylococcus Manganese transporter C (Stap-coc MntC) TTBWX8P W8TNQ9_STAAU Not Available [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035724)
2 ClinicalTrials.gov (NCT01364571) Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years. U.S. National Institutes of Health.